Peptide data sheet
SS-31
Longevity · Elamipretide · MTP-131 · Bendavia
Verdict
promisingfor mitochondrial function in early-stage human research
Quick answer
SS-31 (elamipretide) is a small, mitochondria-targeting research peptide. It is commonly researched for mitochondrial function and cellular energy, and people report interest in recovery and longevity uses. Human evidence is still early, side effects are not fully characterized, and it is not FDA-approved for human use.
- Class
- Mitochondria-targeting tetrapeptide (Szeto-Schiller peptide)
- Half-life
- Short; commonly reported in hours in early studies
- FDA status
- Not FDA-approved; investigational, studied in clinical trials
Which form actually works?
Injectable (subcutaneous, research)
Promising
Most human trials of elamipretide have looked at an injectable form. The signal is early-stage and mixed across conditions; think promising-but-unproven, not settled.
Topical / other routes
Unproven
Non-injectable routes show up in marketing more than in trials. There is little controlled human data here, so treat any topical claims as unproven.